Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Medical and Surgical Education Advances Through the Use of AR Smart Glasses

Vuzix Corporation, a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, announced it has partnered with the Children of War Foundation (COWF) to further the access to medical and surgical education through the use of Vuzix M400 Smart Glasses to connect healthcare professionals and surgeons serving disadvantaged populations in coordination with United States-based academic…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Medical and Surgical Education Advances Through the Use of AR Smart Glasses

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Vuzix Corporation, a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, announced it has partnered with the Children of War Foundation (COWF) to further the access to medical and surgical education through the use of Vuzix M400 Smart Glasses to connect healthcare professionals and surgeons serving disadvantaged populations in coordination with United States-based academic hospital institutions.

Today and in light of the COVID-19 pandemic, much of the Children of War Foundation’s ability to physically mobilize medical teams has slowed down due to travel restrictions. However, with the use of advanced smart glass technology and connectivity, they are expanding their reach more than ever before, connecting team members to its network anytime, anywhere, thanks to Vuzix M400 Smart Glasses. This is being done in partnership with several organizations and implementors, including Vuzix Corporation, Novick Cardiac Alliance, Bernard Mevs Hospital Haiti, Ohana One, and multiple teaching hospitals within and outside the U.S. to deliver access to remote medical and surgical education.

The Children of War Foundation is connecting their network of healthcare professionals across the United States to healthcare professionals and surgeons in disadvantaged areas around the globe with Vuzix M400 Smart Glasses to train and mentor remotely. Over the last ten years, the foundation has improved clinical capabilities at multiple hospitals and healthcare facilities by developing programs to connect mentor healthcare professionals and experts with mentees in underserved regions, supporting programs in the areas of pediatric surgery, neonatal health, surgical innovation and mental health.

“Children of War is excited to partner with Vuzix as our smart glasses supplier to assist our organization to carry out our mission of delivering transformational medical and surgical education through the use of Vuzix smart glasses technology. We can now provide support more quickly and be in places that COVID is preventing access, all at a fraction of the cost,” said Amel Najjar, Founder of Children of War.

“We are very pleased to support Children of War Foundation’s mission and their network of healthcare professionals to deliver medical and surgical education through the use of Vuzix Smart Glasses. To bring this kind of help to the world where and when it is needed is something Vuzix is proud to support,” said Paul Travers, President and CEO of Vuzix.

About Children of War Foundation

Children of War Foundation was established in 2010 initially to help save one child’s life, that child Was 9-year-old Hashim From Baghdad. Children of War Foundation’s mission is to deliver access to transformational healthcare, medical education and infrastructure needs to children and health care professionals effected by war, natural disaster, climate change, poverty, isolation and migration challenges. consumer and enterprise markets. Children of War Foundation has directly impacted over 13,000 lives in partnership with implementing sustainable development goals, partners, affiliates and team members. For more information, visit Children of War Foundation websiteLinkedIn and Facebook pages.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512